Eine Fragebogenstudie zum Disease-Management-Programm Asthma

[1]  H. van den Bussche,et al.  Selection effects may account for better outcomes of the German Disease Management Program for type 2 diabetes , 2010, BMC health services research.

[2]  G. Glaeske,et al.  Effects of a German Asthma Disease Management Program Using Sickness Fund Claims Data , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

[3]  M. Wensing,et al.  Asthma patients with low perceived burden of illness: a challenge for guideline adherence. , 2007, Journal of evaluation in clinical practice.

[4]  M. Seid,et al.  Evidence for the effect of disease management: is $1 billion a year a good investment? , 2007, The American journal of managed care.

[5]  Gregory D. Berg,et al.  A Matched‐Cohort Study of Utilization Outcomes for an Adult Medicaid Population Enrolled in an Asthma Disease Management Program , 2007, The Journal of ambulatory care management.

[6]  L. Steuten,et al.  Health technology assessment of asthma disease management programs , 2007, Current opinion in allergy and clinical immunology.

[7]  S. Palmer,et al.  Cost-utility of a disease management program for patients with asthma , 2007, International Journal of Technology Assessment in Health Care.

[8]  H. Worth,et al.  Evaluation eines strukturierten ambulanten Schulungsprogramms für erwachsene Asthmatiker , 2006 .

[9]  S. Suissa,et al.  Inhaled corticosteroids: impact on asthma morbidity and mortality. , 2001, The Journal of allergy and clinical immunology.